Plasma protein binding of polyphenols from maritime pine bark extract (USP)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 1, 2011, Pages 127-132

  Kurlbaum, Max ^a   Högger, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

High performance affinity chromatography; Human; Maritime pine bark extract; Plasma protein binding; Ultrafiltration

Indexed keywords

BENZOIC ACID DERIVATIVE; CAFFEIC ACID; CATECHIN; CINNAMIC ACID; FERULIC ACID; GALLIC ACID; HUMAN SERUM ALBUMIN; MARITIME PINE BARK EXTRACT; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PROCYANIDIN; PROTOCATECHUIC ACID; TAXIFOLIN; UNCLASSIFIED DRUG; VANILLIC ACID;

ARTICLE; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; ULTRAFILTRATION;

BLOOD PROTEINS; BUFFERS; CALIBRATION; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOIDS; HUMANS; HYDROGEN BONDING; MODELS, CHEMICAL; PHENOLS; PINUS; PLANT EXTRACTS; PROTEIN BINDING; QUERCETIN; REGRESSION ANALYSIS; ULTRAFILTRATION;

EID: 77957016841     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.038     Document Type: Article

References (42)

1. United States Pharmacopeia Maritime Pine Extract 2009, United States Pharmacopeial Convention, Inc., Rockville, pp. 1051-1053.
2. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int. J. Clin. Pharmacol. Ther. 2002, 40:158-168.
3. Rohdewald P.J. Pycnogenol, French Maritime Pine Bark Extract. Encyclopedia of Dietary Supplements 2005, Marcel Dekker, New York, pp. 545-553.
4. Schäfer A., Högger P. Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase. Diab. Res. Clin. Pract. 2007, 77:41-46.
5. Liu X., Wei J., Tan F., Zhou S., Wurthwein G., Rohdewald P. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci. 2004, 75:2505-2513.
6. Liu X., Zhou H.J., Rohdewald P. French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diab. Care 2004, 27:839.
7. Düweler K.G., Rohdewald P. Urinary metabolites of French maritime pine bark extract in humans. Pharmazie 2000, 55:364-368.
8. Virgili F., Pagana G., Bourne L., Rimbach G., Natella F., Rice-Evans C., Packer L. Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract. Free Radic. Biol. Med. 2000, 28:1249-1256.
9. Grimm T., Schäfer A., Högger P. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radic. Biol. Med. 2004, 36:811-822.
10. Grimm T., Skrabala R., Chovanova Z., Muchova J., Sumegova K., Liptakova A., Durackova Z., Högger P. Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers. BMC Clin. Pharmacol. 2006, 6:4.
11. Grimm T., Chovanova Z., Muchova J., Sumegova K., Liptakova A., Durackova Z., Högger P. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J. Inflamm. (London) 2006, 3:1.
12. Schäfer A., Chovanova Z., Muchova J., Sumegova K., Liptakova A., Durackova Z., Högger P. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed. Pharmacother. 2006, 60:5-9.
13. Schmidt S., Gonzalez D., Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 2009, 99:1107-1122.
14. Ishii T., Minoda K., Bae M.J., Mori T., Uekusa Y., Ichikawa T., Aihara Y., Furuta T., Wakimoto T., Kan T., Nakayama T. Binding affinity of tea catechins for HSA: characterization by high-performance affinity chromatography with immobilized albumin column. Mol. Nutr. Food Res. 2010, 54:1-7.
15. Diniz A., Escuder-Gilabert L., Lopes N.P., Villanueva-Camanas R.M., Sagrado S., Medina-Hernandez M.J. Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis. Anal. Bioanal. Chem. 2008.
16. Qian Z.M., Qin S.J., Yi L., Li H.J., Li P., Wen X.D. Binding study of Flos Lonicerae Japonicae with bovine serum albumin using centrifugal ultrafiltration and liquid chromatography. Biomed. Chromatogr. 2008, 22:202-206.
17. Guo M., Su X., Kong L., Li X., Zou H. Characterization of interaction property of multicomponents in Chinese herb with protein by microdialysis combined with HPLC. Anal. Chim. Acta 2006, 556:183-188.
18. Wright J.D., Boudinot F.D., Ujhelyi M.R. Measurement and analysis of unbound drug concentrations. Clin. Pharmacokinet. 1996, 30:445-462.
19. Melten J.W., Wittebrood A.J., Willems H.J., Faber G.H., Wemer J., Faber D.B. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin. J. Pharm. Sci. 1985, 74:692-694.
20. Pacifici G.M, Viani A. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin. Pharmacokinet. 1992, 23:449-468.
21. Nakai D., Kumamoto K., Sakikawa C., Kosaka T., Tokui T. Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. J. Pharm. Sci. 2004, 93:847-854.
22. Hage D.S., Jackson A., Sobansky M.R., Schiel J.E., Yoo M.J., Joseph K.S. Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J. Sep. Sci. 2009, 32:835-853.
23. Taylor S., Harker A. Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids. J. Pharm. Biomed. Anal. 2006, 41:299-303.
24. Thummel K.E., Shen D.D., Isoherranen N., Smith H.E. Design and optimization of dosage regimes; pharmacokinetic data. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2005, 1794-1888. McGraw-Hill, New York. L.L. Brunton, J.S. Lazo, K. Parker (Eds.).
25. Lacy C.F., Armstrong L.L., Goldman M.P., Lance L.L. Drug Information Handbook International 2006, Lexi-Comp, Hudson, OH. 14th ed.
26. Lee K.J., Mower R., Hollenbeck T., Castelo J., Johnson N., Gordon P., Sinko P.J., Holme K., Lee Y.H. Modulation of nonspecific binding in ultrafiltration protein binding studies. Pharm. Res. 2003, 20:1015-1021.
27. Buchholz L., Cai C.H., Andress L., Cleton A., Brodfuehrer J., Cohen L. Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding. Eur. J. Pharm. Sci. 2002, 15:209-215.
28. Ashton D.S., Beddell C.R., Cockerill G.S., Gohil K., Gowrie C., Robinson J.E., Slater M.J., Valko K. Binding measurements of indolocarbazole derivatives to immobilised human serum albumin by high-performance liquid chromatography. J. Chromatogr. B: Biomed. Appl. 1996, 677:194-198.
29. Medic-Saric M., Rastija V., Bojic M., Males Z. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Nutr. J. 2009, 8:33.
30. Adzet T., Camarasa J., Escubedo E., Merlos M. In vitro study of caffeic acid-bovine serum albumin interaction. Eur. J. Drug Metab. Pharmacokinet. 1988, 13:11-14.
31. Manach C., Morand C., Texier O., Favier M.L., Agullo G., Demigne C., Regerat F., Remesy C. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 1995, 125:1911-1922.
32. Soares S., Mateus N., Freitas V. Interaction of different polyphenols with bovine serum albumin (BSA) and human salivary alpha-amylase (HSA) by fluorescence quenching. J. Agric. Food Chem. 2007, 55:6726-6735.
33. Zhang Y., Yue Y., Li J., Chen X. Studies on the interaction of caffeic acid with human serum albumin in membrane mimetic environments. J. Photochem. Photobiol. B 2008, 90:141-151.
34. Kang J., Liu Y., Xie M.X., Li S., Jiang M., Wang Y.D. Interactions of human serum albumin with chlorogenic acid and ferulic acid. Biochim. Biophys. Acta 2004, 1674:205-214.
35. Liu Y., Xie M.X., Jiang M., Wang Y.D. Spectroscopic investigation of the interaction between human serum albumin and three organic acids. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2005, 61:2245-2251.
36. Kratochwil N.A., Huber W., Muller F., Kansy M., Gerber P.R. Predicting plasma protein binding of drugs: a new approach. Biochem. Pharmacol. 2002, 64:1355-1374.
37. Valko K., Nunhuck S., Bevan C., Abraham M.H., Reynolds D.P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. J. Pharm. Sci. 2003, 92:2236-2248.
38. Spencer J.P., Chaudry F., Pannala A.S., Srai S.K., Debnam E., Rice-Evans C. Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 2000, 272:236-241.
39. Zhu Q.Y., Holt R.R., Lazarus S.A., Ensunsa J.L., Hammerstone J.F., Schmitz H.H., Keen C.L. Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa. J. Agric. Food Chem. 2002, 50:1700-1705.
40. Dangles O., Dufour C., Manach C., Morand C., Remesy C. Binding of flavonoids to plasma proteins. Methods Enzymol. 2001, 335:319-333.
41. Baxter N.J., Lilley T.H., Haslam E., Williamson M.P. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry 1997, 36:5566-5577.
42. 2+, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production. A comparison to other extracts or compounds. Free Radic. Res. 2003, 37:573-584.